Literature DB >> 23873509

A systematic approach to analyse the sequelae of LCPD.

Moritz Tannast1, Neil Macintyre, Simon D Steppacher, Harish S Hosalkar, Reinhold Ganz, Klaus A Siebenrock.   

Abstract

The analysis and treatment of hips with healed Legg-Calvé-Perthes disease (LCPD) differs substantially from the treatment in the acute phase of the disease. More specifically, the treating orthopaedic surgeon is often faced with a complex three-dimensional pathomorphology of the hip that is difficult to understand and correct. To date, none of the current classification systems provide a useful decision-making algorithm with regards to the type of surgical intervention necessary to improve hip function in patients with sequelae of LCPD. The conceptual recognition of the femoroacetabular impingement (FAI) and the ability to safely dislocate the hip have revolutionised our diagnostic and therapeutic algorithm for joint-preserving surgery of hips with structural residuals of LCPD. We present a systematic approach to analyse femoral and acetabular pathomorphologic features. The resulting pathomechanisms and the surgical treatment options are presented.

Entities:  

Mesh:

Year:  2013        PMID: 23873509     DOI: 10.5301/hipint.5000071

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  11 in total

1.  Triple osteotomy of the pelvis for Legg-Calve-Perthes disease: a mean fifteen year follow-up.

Authors:  Régis Pailhé; Etienne Cavaignac; Jérôme Murgier; Jean Philippe Cahuzac; Jerôme Sales de Gauzy; Franck Accadbled
Journal:  Int Orthop       Date:  2015-02-03       Impact factor: 3.075

2.  Does surgical hip dislocation and periacetabular osteotomy improve pain in patients with Perthes-like deformities and acetabular dysplasia?

Authors:  John C Clohisy; Jeffrey J Nepple; James R Ross; Gail Pashos; Perry L Schoenecker
Journal:  Clin Orthop Relat Res       Date:  2015-04       Impact factor: 4.176

3.  Clinical outcome of femoral osteotomy in patients with legg-calve´-perthes disease.

Authors:  Mohammad Hallaj Moghadam; Ali Moradi; Farzad Omidi-Kashani
Journal:  Arch Bone Jt Surg       Date:  2013-12-15

4.  Asymmetrically increased femoral version with high prevalence of moderate and severe femoral anteversion in unilateral Legg-Calvé-Perthes disease.

Authors:  Eduardo N Novais; Kianna D Nunally; Mariana G Ferrer; Patricia E Miller; James D Wylie; William T Dodgen
Journal:  J Child Orthop       Date:  2021-10-01       Impact factor: 1.548

Review 5.  [Femoral head reduction osteotomy to improve femoroacetabular containment in Legg-Calve-Perthes disease].

Authors:  Theddy Slongo; Kai Ziebarth
Journal:  Oper Orthop Traumatol       Date:  2022-07-21       Impact factor: 1.286

6.  Simultaneous Morscher's osteotomy and arthroscopic debridement in the management of Legg-Calvé-Perthes disease: a case report and literature review.

Authors:  Batool Bosakhar; Hassan Baldawi; Kathy Liu; Olufemi R Ayeni; Waleed Kishta
Journal:  J Hip Preserv Surg       Date:  2021-06-23

Review 7.  Complications of hip preserving surgery.

Authors:  Markus S Hanke; Till D Lerch; Florian Schmaranzer; Malin K Meier; Simon D Steppacher; Klaus A Siebenrock
Journal:  EFORT Open Rev       Date:  2021-06-28

8.  Femoral head necrosis and progressive osteoarthritis of a healed intracapital osteotomy in a severe sequelae of Legg-Calvé-Perthes disease with aplasia of tensor fasciae latae.

Authors:  Filippo Randelli; Athanasios Papavasiliou; Manuel G Mazzoleni; Alberto Fioruzzi; Giuseppe Basile; Reinhold Ganz
Journal:  J Hip Preserv Surg       Date:  2021-06-23

Review 9.  Imaging of femoroacetabular impingement-current concepts.

Authors:  Christoph E Albers; Nicholas Wambeek; Markus S Hanke; Florian Schmaranzer; Gareth H Prosser; Piers J Yates
Journal:  J Hip Preserv Surg       Date:  2016-11-10

10.  Is Legg-Calvé-Perthes Disease a Local Manifestation of a Systemic Condition?

Authors:  Yasmin D Hailer; Nils P Hailer
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.